Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States-Reference-Cited by-同舟云学术

Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States

Published:2014-01-27 Issue:1 Volume:9 Page:e85554
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pulte Dianne,Jansen Lina,Gondos Adam,Katalinic Alexander,Barnes Benjamin,Ressing Meike,Holleczek Bernd,Eberle Andrea,Brenner Hermann,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Treatment of acute lymphoblastic leukemia;CH Pui;N Engl J Med,2006

2. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst;D Pulte,2008

3. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States 1981–2005;D Pulte;Cancer,2009

4. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21^st century;D Pulte;Blood,2009

5. Fielding A (2008) The treatment of adults with acute lymphoblastic leukemia. Hematology 381–9.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function;Cellular Oncology;2024-05-29

2. Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia;Annals of Hematology;2024-03-07

3. Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis;Clinical Therapeutics;2024-01

4. Synthesis, anti-leukemia activity, and molecular docking of novel 3,16-androstenedione derivatives;Steroids;2023-11

5. Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients;Advances in Therapy;2023-10-06